White & Case Advises Armira on PharOS Stake Acquisition
Deal News | Nov 07, 2024 | White & Case
White & Case LLP has advised Armira in its strategic acquisition of a 40 percent stake in PharOS, a global leader in the pharmaceutical industry headquartered in Athens. The transaction showcases Armira's focus on direct equity investments in medium-sized, family businesses and growing companies, and further affirms White & Case's expertise in handling complex, cross-border transactions. Founded in 2002, PharOS has grown significantly, with over 470 clients across 115 countries and manages 9,200 marketing authorizations worldwide. While Armira and Viessmann Generations Group acquire this stake, the founders, Stella Koukaki, Theodore Panagopoulos, and Panagiotis Panagopoulos, will maintain majority ownership, ensuring the company's adherence to its strategic direction.
Sectors
- Pharmaceuticals
- Legal Services
- Private Equity
Geography
- Greece – PharOS is headquartered in Athens, making Greece a primary geographic focus.
- Germany – Armira, an investment company, likely has operations or influence in Germany.
- United Kingdom – Part of the White & Case team advising on the deal is based in London.
- United Arab Emirates – Part of the White & Case team's involvement is from Dubai and Abu Dhabi offices.
- Belgium – White & Case partners and associates involved in the deal hail from Brussels.
- Sweden – One of the White & Case partners involved in the deal holds a presence in Stockholm.
Industry
- Pharmaceuticals – PharOS operates within the pharmaceutical sector, providing product launches and managing marketing authorizations globally.
- Legal Services – White & Case LLP is providing legal services, advising Armira on the acquisition.
- Private Equity – Armira is a prominent investment company engaging in private equity transactions.
Financials
- 40% – Stake acquired by Armira in PharOS.
Participants
| Name | Role | Type | Description |
|---|---|---|---|
| White & Case LLP | Legal Advisor | Company | A global law firm advising Armira on the acquisition of PharOS. |
| Armira | Buyer | Company | An investment company acquiring a 40% stake in PharOS. |
| PharOS | Target | Company | A company in the pharmaceutical industry receiving investment from Armira. |
| Viessmann Generations Group | Co-investor | Company | Co-invested alongside Armira in the acquisition of a stake in PharOS. |
| Stella Koukaki | Founder and Majority Owner | Person | Founder and majority owner of PharOS. |
| Theodore Panagopoulos | Founder and Majority Owner | Person | Founder and majority owner of PharOS. |
| Panagiotis Panagopoulos | Founder and Majority Owner | Person | Founder and majority owner of PharOS. |
| Marcus Booth | Partner | Person | A partner at White & Case who co-led the firm's deal team. |